Phibro Animal Health Corp [PAHC] stock is trading at $29.9, up 6.79%. An important factor to consider is whether the stock is rising or falling in short-term value. The PAHC shares have gain 16.52% over the last week, with a monthly amount glided 24.74%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Phibro Animal Health Corp [NASDAQ: PAHC] stock has seen the most recent analyst activity on July 07, 2025, when JP Morgan upgraded its rating to a Overweight but kept the price target unchanged to $35 for it. Previously, BNP Paribas Exane upgraded its rating to Neutral on June 16, 2025, and kept the price target unchanged to $24. On September 10, 2024, JP Morgan initiated with a Neutral rating and assigned a price target of $22 on the stock. Exane BNP Paribas started tracking the stock assigning a Underperform rating and suggested a price target of $9 on December 07, 2023. ROTH Capital initiated its recommendation with a Buy and recommended $18 as its price target on December 21, 2022. Barclays downgraded its rating to Underweight for this stock on July 25, 2022, but kept the price target unchanged to $22. In a note dated January 10, 2022, Barclays upgraded an Equal Weight rating on this stock but restated the target price of $23.
Phibro Animal Health Corp [PAHC] stock has fluctuated between $16.16 and $28.49 over the past year. Currently, Wall Street analysts expect the stock to reach $26 within the next 12 months. Phibro Animal Health Corp [NASDAQ: PAHC] shares were valued at $29.9 at the most recent close of the market. An investor can expect a potential drop of -13.04% based on the average PAHC price forecast.
Analyzing the PAHC fundamentals
Phibro Animal Health Corp [NASDAQ:PAHC] reported sales of 1.19B for the trailing twelve months, which represents a growth of 32.14%. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.12 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of2.89.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 29.11 points at the first support level, and at 28.33 for the second support level. However, for the 1st resistance point, the stock is sitting at 30.64, and for the 2nd resistance point, it is at 31.38.
Ratios To Look Out For
For context, Phibro Animal Health Corp’s Current Ratio is 2.91. On the other hand, the Quick Ratio is 1.23, and the Cash Ratio is 0.23. Considering the valuation of this stock, the price to sales ratio is 1.02, the price to book ratio is 4.56 and price to earnings (TTM) ratio is 38.26.
Transactions by insiders
Recent insider trading involved BFI Co., LLC, 10% Owner, that happened on May 19 ’25 when 0.24 million shares were purchased. Director, CORCORAN E THOMAS completed a deal on Feb 24 ’25 to buy 5000.0 shares. Meanwhile, 10% Owner BFI Co., LLC bought 0.25 million shares on Feb 18 ’25.
